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Figure 6. Overexpression of Dsg3 in cancer cell lines induces 
membrane protrusion and promotes cell migration and invasion. 
Figure 5. Overexpression of Dsg3 enhances phosphorylation of c-Jun 
S63 and activates the AP-1 transcriptional activity. 
Figure 4. Overexpression of Dsg3 activates Ezrin-T567 that could be 
abrogated by the PKC and ROCK inhibitions.
Desmoglein 3 Acts as a Potential Oncogene in Promoting Cancer Cell Migration and 
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Introduction
Desmoglein 3 (Dsg3) is an adhesion protein in desmosomes that confer strong cell-cell
adhesion in epithelia. It is best known as the autoantigen of pemphigus vulgaris, a life
threatening blistering disease, caused by autoantibodies targeting Dsg3 which lead to
the loss of cell cohesion in the skin and oral mucosa. However, the upregulation of Dsg3
in cancers has been reported recently though the mechanism remains poorly defined.
The actin-binding protein Ezrin is an important regulator of membrane cytoskeleton,
whereas AP-1 is a dimeric transcription factor composed of proteins including c-Jun/ c-
Fos. Both Ezrin and AP-1 are implicated in cancers, especially in the invasive phenotype,
and can be activated by Protein kinase C (PKC) and Rho kinase (ROCK). The aim of this
study was to investigate the hypothesis that Dsg3 plays a role in regulating Ezrin and
AP-1 that could be attributed to cancer cell migration and invasion.
Louise Brown1*, Edel O’Toole2 and Hong Wan1 
Queen Mary University of London, Barts and The London, School of Medicine and Dentistry, 1 Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry,
2 Centre for Cutaneous Research, Blizard Institute, Whitechapel, London E1 2AT 
* Current address: Department of Cellular and Molecular Physiology, University of Liverpool, Institute of Translational Medicine, Liverpool L69 3BX
www.SMD@qmul.ac.uk
Desmosome structure/ protein components
(A) The enhanced Ezrin-T567 in Dsg3 overexpressing 
cells was inhibited by a PKC inhibitor, BIM, in a dose-
dependent manner. (B) The phosphorylation of Ezrin-
T567 can also be blocked by various inhibitors 
including that to PKC, ROCK as well as p38 MAPK.  
 Dsg3 associates with Ezrin at the plasma
membrane and regulates its activity through
T567 phosphorylation.
 The Dsg3 mediated Ezrin activation can be
abrogated by PKC inhibition, as well as by
several other inhibitors, suggesting it is at least
PKC-dependent.
 Our data from this study as well as others
suggest that Dsg3 acts as a key regulator for
several signal pathways that are essential for
the actin-based membrane morphology and
cell migration and invasion.
(A) Confocal images showed partial colocalisation of Dsg3 with Ezrin at the plasma membrane.
Arrowheads: Dsg3 expression at the tips of membrane protrusions. (B) Co-IP demonstrated
these two proteins formed a complex in Dsg3 dose-dependent manner. Their association was
also supported by Proximity Ligation assay and the FRET analysis (data not shown).
(A) Fluorescent microscopy of A431-D3 with and without Dsg3 silencing showed that the
pronounced membrane protrusions were abolished by Dsg3 depletion with concomitant
reduction of E-cadherin. (B) Raft culture indicated that overexpression of Dsg3 in SqCC/Y1 oral
cancer line promoted cell invasion. (C) Quantitation of cell invasion in (B) (***p<0.001).
Figure 2. Dsg3 silencing affects colocalisation of Ezrin with F-actin and 















Figure 1. Dsg3 colocalises and is physically associated with Ezrin at 
the plasma membrane.
Immunofluorescence showed 
that Dsg3 silencing 
significantly reduced the 
associations of CD44/ F-
actin and Ezrin/ F-actin, 
respectively, indicating that 
Dsg3 regulates the Ezrin 
activity at the plasma 
membrane and its 
association with other 




(A) Pospho-kinase array (part of the data) of A431-D3 normalized against to A431-V control
cells showed a significant increase of phospho-c-Jun S63 among other kinases. (B) luciferase
assay indicated that Dsg3 regulated the AP-1 promoter activity. (C) Dsg3 silencing reduced the
luciferase activity more than 2-fold. (**p<0.01, ***p<0.001).
Figure 3. Overexpression of Dsg3 enhances Ezrin phosphorylation at 
T567 (activates Ezrin).
Western blotting analysis 
indicated that cells with 
overexpression of Dsg3 showed 
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